Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

NKHP reported for 9 months of 2023 by RAS

10/23/23 NKHP

VK Tech became a partner of system integrator Mobius Technologies

10/23/23 VKCO

X5 Retail Group announced the acquisition of lease rights for the Grozd chain stores

10/23/23 FIVE

Severstal's sales remained at the same level as last year

10/23/23 CHMF

Rusagro summarized the results of 9 months of 2023

10/23/23 RAGR

Lenta reported for 9 months of 2023

10/23/23 LENT

Lenta's operating performance is in the plus zone

10/23/23 LENT

CarMoney's loan portfolio reached ₽4.754 billion

10/23/23 CARM

In M.Video will open corners of Turkish and Chinese brands

10/23/23 MVID

Softline buys 5% of Moscow Exchange at a 60% discount

10/23/23 MOEX